BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20132976)

  • 1. Naturally processed T cell-activating peptides of the major birch pollen allergen.
    Mutschlechner S; Egger M; Briza P; Wallner M; Lackner P; Karle A; Vogt AB; Fischer GF; Bohle B; Ferreira F
    J Allergy Clin Immunol; 2010 Mar; 125(3):711-8, 718.e1-718.e2. PubMed ID: 20132976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of T cell epitopes unique to Cha o 2, the major allergen in Japanese cypress pollen, in allergic patients cross-reactive to Japanese cedar and Japanese cypress pollen.
    Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
    Allergol Int; 2009 Jun; 58(2):237-45. PubMed ID: 19307778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
    Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
    J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoallergenic derivatives of the major birch pollen allergen Bet v 1 obtained by rational sequence reassembly.
    Campana R; Vrtala S; Maderegger B; Jertschin P; Stegfellner G; Swoboda I; Focke-Tejkl M; Blatt K; Gieras A; Zafred D; Neubauer A; Valent P; Keller W; Spitzauer S; Valenta R
    J Allergy Clin Immunol; 2010 Nov; 126(5):1024-31, 1031.e1-8. PubMed ID: 20638112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season.
    Grindebacke H; Wing K; Andersson AC; Suri-Payer E; Rak S; Rudin A
    Clin Exp Allergy; 2004 Sep; 34(9):1364-72. PubMed ID: 15347368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bet v 1 and its homologous food allergen Api g 1 stimulate dendritic cells from birch pollen-allergic individuals to induce different Th-cell polarization.
    Smole U; Wagner S; Balazs N; Radauer C; Bublin M; Allmaier G; Hoffmann-Sommergruber K; Breiteneder H
    Allergy; 2010 Nov; 65(11):1388-96. PubMed ID: 20557297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological characteristics of subjects with asymptomatic skin sensitization to birch and grass pollen.
    Assing K; Nielsen CH; Poulsen LK
    Clin Exp Allergy; 2006 Mar; 36(3):283-92. PubMed ID: 16499638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of allergenicity and immunogenicity of an intact allergen vaccine and commercially available allergoid products for birch pollen immunotherapy.
    Lund L; Henmar H; Würtzen PA; Lund G; Hjortskov N; Larsen JN
    Clin Exp Allergy; 2007 Apr; 37(4):564-71. PubMed ID: 17430354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hypoallergenic variant of the major birch pollen allergen shows distinct characteristics in antigen processing and T-cell activation.
    Kitzmüller C; Wallner M; Deifl S; Mutschlechner S; Walterskirchen C; Zlabinger GJ; Ferreira F; Bohle B
    Allergy; 2012 Nov; 67(11):1375-82. PubMed ID: 22973879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oralair Birch, a recombinant major birch pollen allergen tablet for sublingual immunotherapy of allergic rhinitis caused by birch pollen.
    Larenas-Linnemann D
    Curr Opin Investig Drugs; 2010 May; 11(5):586-96. PubMed ID: 20419605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell epitopes in Japanese cedar (Cryptomeria japonica) pollen allergens: choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for the management of Japanese cedar pollinosis.
    Sone T; Morikubo K; Miyahara M; Komiyama N; Shimizu K; Tsunoo H; Kino K
    J Immunol; 1998 Jul; 161(1):448-57. PubMed ID: 9647255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential T-cell responses and allergen uptake after exposure of dendritic cells to the birch pollen allergens Bet v 1.0101, Bet v 1.0401 and Bet v 1.1001.
    Smole U; Balazs N; Hoffmann-Sommergruber K; Radauer C; Hafner C; Wallner M; Ferreira F; Grössinger R; de Jong EC; Wagner S; Breiteneder H
    Immunobiology; 2010 Nov; 215(11):903-9. PubMed ID: 20005001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class II peptide tetramers vs allergen-induced proliferation for identification of allergen-specific CD4 T cells.
    Van Hemelen D; Mahler V; Fischer G; Fae I; Reichl-Leb V; Pickl W; Jutel M; Smolinska S; Ebner C; Bohle B; Jahn-Schmid B
    Allergy; 2015 Jan; 70(1):49-58. PubMed ID: 25236500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind placebo-controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentation.
    Würtzen PA; Lund G; Lund K; Arvidsson M; Rak S; Ipsen H
    Clin Exp Allergy; 2008 Aug; 38(8):1290-301. PubMed ID: 18510696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodominance in allergic T-cell reactivity to Japanese cedar in different geographic cohorts.
    Oseroff C; Pham J; Frazier A; Hinz D; Sidney J; Paul S; Greenbaum JA; Vita R; Peters B; Schulten V; Sette A
    Ann Allergy Asthma Immunol; 2016 Dec; 117(6):680-689.e1. PubMed ID: 27979027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral Th-17 cells in allergic rhinitis: New evidence.
    Ciprandi G; Filaci G; Battaglia F; Fenoglio D
    Int Immunopharmacol; 2010 Feb; 10(2):226-9. PubMed ID: 19925886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of T cell epitopes on birch pollen allergen].
    Mizumoto K; Kimura S; Abe Y; Uehara M; Katagiri M
    Hokkaido Igaku Zasshi; 1997 Jan; 72(1):59-67. PubMed ID: 9086363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The allergen Bet v 1 in fractions of ambient air deviates from birch pollen counts.
    Buters JT; Weichenmeier I; Ochs S; Pusch G; Kreyling W; Boere AJ; Schober W; Behrendt H
    Allergy; 2010 Jul; 65(7):850-8. PubMed ID: 20132158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of CD4+CD25+CD127lo regulatory T cells does not increase allergen-driven T cell activation.
    Skrindo I; Farkas L; Kvale EO; Johansen FE; Jahnsen FL
    Clin Exp Allergy; 2008 Nov; 38(11):1752-9. PubMed ID: 18681851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients.
    Ebner C; Schenk S; Najafian N; Siemann U; Steiner R; Fischer GW; Hoffmann K; Szépfalusi Z; Scheiner O; Kraft D
    J Immunol; 1995 Feb; 154(4):1932-40. PubMed ID: 7530747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.